Halozyme Therapeutics Inc (NASDAQ:HALO)

17.74
Delayed Data
As of May 26
 +0.29 / +1.66%
Today’s Change
7.51
Today|||52-Week Range
17.87
+83.83%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close17.45
Today’s open17.37
Day’s range17.15 - 17.87
Volume1,960,765
Average volume (3 months)1,350,088
Market cap$2.2B
Dividend yield--
Data as of 3:59pm ET, 05/26/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+15.68%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book53.05

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc-1.64-3.10%
NVAXNovavax Inc+0.02+0.23%
ESPREsperion Therapeutic...-4.19-3.88%
RDUSRadius Health Inc+0.83+1.73%
Data as of 3:59pm ET, 05/26/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers